27 min listen
There’s no clear evidence that most new cancer drugs extend or improve life
FromThe BMJ Podcast
ratings:
Length:
24 minutes
Released:
Oct 5, 2017
Format:
Podcast episode
Description
The majority of cancer drugs approved in Europe between 2009 and 2013 entered the market without clear evidence that they improved survival or quality of life for patients, finds a study published by The BMJ today.
Even where drugs did show survival gains over existing treatments, these were often marginal.
To discuss that, we're joined by Huseyin Naci, assistant professor of health policy at the London School of Economics.
Read the open access study: http://www.bmj.com/content/359/bmj.j4530
Even where drugs did show survival gains over existing treatments, these were often marginal.
To discuss that, we're joined by Huseyin Naci, assistant professor of health policy at the London School of Economics.
Read the open access study: http://www.bmj.com/content/359/bmj.j4530
Released:
Oct 5, 2017
Format:
Podcast episode
Titles in the series (100)
Plain Packaging: Plain packaging on tobacco products is the latest strategy aimed at reducing smoking. Campaigners had hoped the UK would follow Australia’s example. But they have been disappointed as the UK government postpones the plans until “more evidence” is ava... by The BMJ Podcast